BridgeMD
New treatment option for Stroke
Official title Effects of Augmented Reality (AR) and Transcranial Direct Current Stimulation (tDCS)
ClinicalTrials.gov ID: NCT07629791
What this study is testing
- What it's testing
- The aim of this randomized controlled trial is to determine the effects of Augmented Reality (AR)-based balance training on improving balance and postural control in chronic stroke survivors and whether the addition of transcranial Direct Current Stimulation (tDCS) to AR training produces superior outcomes compared to AR training alone.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 90
You may be able to join if
- Balance impairment confirmed by Berg Balance Scale (BBS) score 21-44.
- Age between 18-90 years.
- Mild or no spasticity in lower limb (MAS ≤ 2)
- have sufficient cognition to follow the instructions provided by the therapists and the computer.
You likely can't join if
- Individuals with implanted electronic devices (e.g., pacemakers), due to interaction risk with tDCS
- Other medical or psychological conditions affecting participation (e.g., severe pain, epilepsy, pacemaker).
- Patients with severe cognitive deficits or visual impairments
The study team makes the final eligibility decision.
Where it's taking place
- Rawalpindi, Punjab Province, Pakistan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 90 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Rawalpindi, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.